Evaluation of fine needle biopsy (FNB) for endoscopic ultrasound (EUS) guided tissue acquisition of pancreatic masses to negate the need for rapid on-site evaluation: a multi-centre randomized control trial
Recruiting
- Conditions
- Investigation and diagnosis of pancreatic lesions / massesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12617001011370
- Lead Sponsor
- Royal Adelaide Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 598
Inclusion Criteria
1. Aged 18 years old or over
2. Patients requiring endoscopic ultrasound and tissue sampling of solid lesions greater than 1cm diameter in the pancreas that are visualized and within the reach of EUS FNA.
Exclusion Criteria
1. Pregnant females
2. Uncorrectable coagulation disorder (INR > 1.5)
3. Those with medical co-morbidities that preclude them from sedation (as determined by anaesthetic team)
4. Actively on medications that increase the risk of bleeding from EUS guided tissue acquisition (NOAC, warfarin, combined aspirin and clopidogrel)
5. Those unable to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method